Pure Global

Exposing Narrative Exposure Therapy - Trial NCT05383846

Access comprehensive clinical trial information for NCT05383846 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Nottingham and is currently Not yet recruiting. The study focuses on Traumatic Stress Disorder. Target enrollment is 4 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05383846
Not yet recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT05383846
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Exposing Narrative Exposure Therapy

Study Focus

Traumatic Stress Disorder

Experimental Narrative Exposure Therapy

Interventional

other

Sponsor & Location

University of Nottingham

Nottingham, United Kingdom

Timeline & Enrollment

N/A

Jan 14, 2022

Dec 30, 2022

4 participants

Primary Outcome

Change in autobiographical memory integration during NET intervention. A coding manual has been created by the research team to assess the posited mechanism of change- Autobiographical Memory Integration Coding Tool

Summary

The main purpose of the study is to further develop an existing measure of autobiographical
 memory integration (ABMI) to investigate and clarify the ABMI change process specific to
 narrative exposure therapy (NET).

ICD-10 Classifications

Post-traumatic stress disorder
Traumatic shock
Personal history of psychological trauma, not elsewhere classified
State of emotional shock and stress, unspecified
Reaction to severe stress, unspecified

Data Source

ClinicalTrials.gov

NCT05383846

Non-Device Trial